Grey parrot
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Psittaciformes; Psittacidae; Psittacus,
Latin Name:
Psittacus erithacus
Tested tissues: PBMC,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0054 | 2021.04 | iDrop | PBMC | Normal | 1406 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Dengue virus |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; PBMC-Neutrophil : 17.74% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Dendritic cells : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-Macrophages : 8.42% ; PBMC-T cells : 0.25% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Adeno-associated virus - 2 |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; PBMC-Platelets : 5.56% ; PBMC-B cells : 5.38% ; PBMC-Erythroid Progenitors : 5.05% ; PBMC-Macrophages : 4.21% ; PBMC-T cells : 3.70% ; |
|
Adeno-associated virus - 8 |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; |
|
Classical swine fever virus |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; |
|
Adeno-associated virus 9 |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; |
|
Sindbis virus |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; |
|
Adeno-associated virus - 3 |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; |
|
Venezuelan equine encephalitis virus |
PBMC-Macrophages : 95.79% ; PBMC-T cells : 91.11% ; PBMC-B cells : 88.17% ; PBMC-Platelets : 51.85% ; PBMC-Erythroid Progenitors : 37.77% ; |
|
Equid alphaherpesvirus 1 | |
|
Human immunodeficiency virus 1 | |
|
Feline immunodeficiency virus | |
|
Human immunodeficiency virus 2 | |
|
Simian rotavirus A strain RRV |
PBMC-Macrophages : 67.37% ; PBMC-T cells : 63.70% ; PBMC-B cells : 47.31% ; PBMC-Neutrophil : 46.77% ; PBMC-Dendritic cells : 44.19% ; PBMC-Macrophages : 49.47% ; PBMC-Neutrophil : 6.45% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.47% ; PBMC-Platelets : 1.85% ; PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; PBMC-Platelets : 29.63% ; PBMC-Neutrophil : 8.06% ; PBMC-Macrophages : 6.32% ; PBMC-T cells : 1.48% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Platelets : 1.85% ; PBMC-Erythroid Progenitors : 0.46% ; PBMC-T cells : 0.25% ; PBMC-B cells : 0.00% ; PBMC-Macrophages : 0.00% ; |
|
Lassa mammarenavirus |
PBMC-Macrophages : 61.05% ; PBMC-Platelets : 14.81% ; PBMC-Erythroid Progenitors : 11.31% ; PBMC-Neutrophil : 11.29% ; PBMC-B cells : 10.75% ; PBMC-Platelets : 14.81% ; PBMC-Macrophages : 7.37% ; PBMC-T cells : 2.72% ; PBMC-Dendritic cells : 2.33% ; PBMC-Neutrophil : 1.61% ; PBMC-Macrophages : 8.42% ; PBMC-T cells : 0.25% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Influenza A virus |
PBMC-Macrophages : 58.95% ; PBMC-T cells : 10.62% ; PBMC-Neutrophil : 6.45% ; PBMC-Platelets : 3.70% ; PBMC-B cells : 2.15% ; PBMC-Macrophages : 29.47% ; PBMC-B cells : 6.45% ; PBMC-Neutrophil : 4.84% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.72% ; PBMC-Platelets : 1.85% ; PBMC-Erythroid Progenitors : 0.46% ; PBMC-T cells : 0.25% ; PBMC-B cells : 0.00% ; PBMC-Macrophages : 0.00% ; PBMC-T cells : 1.23% ; PBMC-B cells : 1.08% ; PBMC-Macrophages : 0.00% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
|
Coxsackievirus A9 |
PBMC-Macrophages : 49.47% ; PBMC-Neutrophil : 6.45% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.47% ; PBMC-Platelets : 1.85% ; PBMC-Platelets : 29.63% ; PBMC-Neutrophil : 8.06% ; PBMC-Macrophages : 6.32% ; PBMC-T cells : 1.48% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Macrophages : 5.26% ; PBMC-T cells : 0.74% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
West Nile virus | |
|
Human mastadenovirus C | |
|
Foot-and-mouth disease virus |
PBMC-Macrophages : 49.47% ; PBMC-Neutrophil : 6.45% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.47% ; PBMC-Platelets : 1.85% ; PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; PBMC-Platelets : 29.63% ; PBMC-Neutrophil : 8.06% ; PBMC-Macrophages : 6.32% ; PBMC-T cells : 1.48% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Macrophages : 5.26% ; PBMC-T cells : 0.74% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; |
|
Human betaherpesvirus 5 |
PBMC-Macrophages : 49.47% ; PBMC-Neutrophil : 6.45% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.47% ; PBMC-Platelets : 1.85% ; PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; PBMC-Platelets : 29.63% ; PBMC-Neutrophil : 8.06% ; PBMC-Macrophages : 6.32% ; PBMC-T cells : 1.48% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-T cells : 1.23% ; PBMC-B cells : 1.08% ; PBMC-Platelets : 0.00% ; PBMC-Macrophages : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Human alphaherpesvirus 1 | |
|
Human parechovirus 1 | |
|
Human gammaherpesvirus 8 | |
|
Coxsackievirus B1 |
PBMC-Macrophages : 49.47% ; PBMC-Neutrophil : 6.45% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.47% ; PBMC-Platelets : 1.85% ; PBMC-Macrophages : 5.26% ; PBMC-T cells : 0.74% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Echovirus E1 | |
|
Human metapneumovirus |
PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; |
|
Human rotavirus strain WA | |
|
Echovirus E8 | |
|
Human gammaherpesvirus 4 |
PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; |
|
Human parvovirus B19 |
PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; |
|
Mammalian orthoreovirus |
PBMC-Macrophages : 48.42% ; PBMC-Platelets : 37.04% ; PBMC-T cells : 22.96% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; |
|
Bovine leukemia virus |
PBMC-Macrophages : 47.37% ; PBMC-Neutrophil : 20.97% ; PBMC-Dendritic cells : 18.60% ; PBMC-T cells : 18.02% ; PBMC-Erythroid Progenitors : 17.28% ; |
|
Hepacivirus C |
PBMC-Macrophages : 41.05% ; PBMC-Platelets : 14.81% ; PBMC-T cells : 14.32% ; PBMC-Neutrophil : 6.45% ; PBMC-B cells : 4.30% ; PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; PBMC-Neutrophil : 17.74% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Dendritic cells : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-Dendritic cells : 2.33% ; PBMC-Platelets : 1.85% ; PBMC-Macrophages : 1.05% ; PBMC-T cells : 0.74% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-T cells : 1.23% ; PBMC-B cells : 1.08% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Feline panleukopenia virus |
PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; |
|
Machupo mammarenavirus |
PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; |
|
Canine parvovirus |
PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; |
|
Argentinian mammarenavirus |
PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; |
|
Mouse mammary tumor virus |
PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; |
|
Guanarito mammarenavirus |
PBMC-Erythroid Progenitors : 40.21% ; PBMC-B cells : 24.73% ; PBMC-Platelets : 20.37% ; PBMC-T cells : 17.04% ; PBMC-Macrophages : 9.47% ; |
|
Enterovirus A71 | |
|
Hantaan orthohantavirus |
PBMC-Platelets : 29.63% ; PBMC-Neutrophil : 8.06% ; PBMC-Macrophages : 6.32% ; PBMC-T cells : 1.48% ; PBMC-Erythroid Progenitors : 0.15% ; |
|
Vesicular stomatitis virus |
PBMC-Macrophages : 29.47% ; PBMC-B cells : 6.45% ; PBMC-Neutrophil : 4.84% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.72% ; |
|
Chikungunya virus | |
|
Polytropic murine leukemia virus |
PBMC-Macrophages : 23.16% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; PBMC-T cells : 7.41% ; PBMC-Dendritic cells : 6.98% ; |
|
Xenotropic murine leukemia virus |
PBMC-Macrophages : 23.16% ; PBMC-B cells : 11.83% ; PBMC-Neutrophil : 8.06% ; PBMC-T cells : 7.41% ; PBMC-Dendritic cells : 6.98% ; |
|
Human papillomavirus type 16 | |
|
Human mastadenovirus B |
PBMC-Macrophages : 15.79% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Ebola virus |
PBMC-Macrophages : 15.79% ; PBMC-Neutrophil : 12.90% ; PBMC-B cells : 5.38% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 2.96% ; PBMC-Macrophages : 8.42% ; PBMC-T cells : 0.25% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; PBMC-Macrophages : 3.16% ; PBMC-B cells : 1.08% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Feline leukemia virus strain B/lambda-B1 | |
|
Gibbon ape leukemia virus | |
|
Simian sarcoma-associated virus |
PBMC-Erythroid Progenitors : 15.60% ; PBMC-Macrophages : 7.37% ; PBMC-B cells : 6.45% ; PBMC-Dendritic cells : 4.65% ; PBMC-T cells : 3.95% ; |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Latino mammarenavirus |
PBMC-Platelets : 14.81% ; PBMC-Macrophages : 7.37% ; PBMC-T cells : 2.72% ; PBMC-Dendritic cells : 2.33% ; PBMC-Neutrophil : 1.61% ; |
|
Oliveros mammarenavirus |
PBMC-Platelets : 14.81% ; PBMC-Macrophages : 7.37% ; PBMC-T cells : 2.72% ; PBMC-Dendritic cells : 2.33% ; PBMC-Neutrophil : 1.61% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
PBMC-Platelets : 12.96% ; PBMC-B cells : 3.23% ; PBMC-Macrophages : 3.16% ; PBMC-Dendritic cells : 2.33% ; PBMC-Neutrophil : 1.61% ; |
|
Porcine reproductive and respiratory syndrome virus |
PBMC-Macrophages : 10.53% ; PBMC-Dendritic cells : 2.33% ; PBMC-Platelets : 1.85% ; PBMC-B cells : 1.08% ; PBMC-T cells : 0.99% ; |
|
Marburg marburgvirus | |
|
Zika virus |
PBMC-Macrophages : 8.42% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; |
|
Amphotropic murine leukemia virus |
PBMC-B cells : 7.53% ; PBMC-Platelets : 7.41% ; PBMC-Neutrophil : 3.23% ; PBMC-Dendritic cells : 2.33% ; PBMC-Macrophages : 2.11% ; |
|
Coxsackievirus A10 |
PBMC-Platelets : 7.41% ; PBMC-Dendritic cells : 2.33% ; PBMC-T cells : 1.23% ; PBMC-B cells : 1.08% ; PBMC-Macrophages : 1.05% ; |
|
Simian immunodeficiency virus |
PBMC-T cells : 7.16% ; PBMC-Macrophages : 3.16% ; PBMC-Platelets : 1.85% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-B cells : 0.00% ; |
|
Human betaherpesvirus 7 |
PBMC-T cells : 7.16% ; PBMC-Macrophages : 3.16% ; PBMC-Platelets : 1.85% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-B cells : 0.00% ; |
|
Human alphaherpesvirus 3 |
PBMC-B cells : 6.45% ; PBMC-Erythroid Progenitors : 5.66% ; PBMC-Macrophages : 5.26% ; PBMC-T cells : 4.44% ; PBMC-Dendritic cells : 2.33% ; |
|
Varicella Zoster Virus |
PBMC-B cells : 6.45% ; PBMC-Erythroid Progenitors : 5.66% ; PBMC-Macrophages : 5.26% ; PBMC-T cells : 4.44% ; PBMC-Dendritic cells : 2.33% ; |
|
Japanese encephalitis virus |
PBMC-Platelets : 5.56% ; PBMC-Macrophages : 3.16% ; PBMC-Neutrophil : 1.61% ; PBMC-T cells : 0.25% ; PBMC-B cells : 0.00% ; |
|
Jaagsiekte sheep retrovirus |
PBMC-Platelets : 5.56% ; PBMC-Macrophages : 1.05% ; PBMC-T cells : 0.25% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
|
Respiratory syncytial virus |
PBMC-T cells : 5.43% ; PBMC-Dendritic cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-Macrophages : 0.00% ; |
|
Human mastadenovirus F |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; |
|
Coxsackievirus B5 |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
|
Human mastadenovirus D |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Coxsackievirus B6 |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Coxsackievirus B3 |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Coxsackievirus B2 |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Human mastadenovirus E |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; |
|
Coxsackievirus B4 |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; |
|
Human mastadenovirus A |
PBMC-Macrophages : 4.21% ; PBMC-Erythroid Progenitors : 0.31% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; |
|
Coxsackievirus A16 |
PBMC-Macrophages : 4.21% ; PBMC-Platelets : 1.85% ; PBMC-T cells : 1.48% ; PBMC-Erythroid Progenitors : 0.46% ; PBMC-Dendritic cells : 0.00% ; |
|
Feline leukemia virus strain C/FA27 |
PBMC-B cells : 3.23% ; PBMC-Dendritic cells : 2.33% ; PBMC-Macrophages : 2.11% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.15% ; |
|
Hendra henipavirus |
PBMC-Macrophages : 2.11% ; PBMC-B cells : 1.08% ; PBMC-T cells : 0.74% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Platelets : 0.00% ; |
|
Nipah henipavirus |
PBMC-Macrophages : 2.11% ; PBMC-B cells : 1.08% ; PBMC-T cells : 0.74% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Platelets : 0.00% ; |
|
Middle East respiratory syndrome-related coronavirus |
PBMC-Platelets : 1.85% ; PBMC-B cells : 1.08% ; PBMC-Macrophages : 1.05% ; PBMC-T cells : 0.25% ; PBMC-Dendritic cells : 0.00% ; |
|
Human betaherpesvirus 6B |
PBMC-Platelets : 1.85% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
|
Encephalomyocarditis virus |
PBMC-B cells : 1.08% ; PBMC-Macrophages : 1.05% ; PBMC-T cells : 0.74% ; PBMC-Platelets : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Ecotropic murine leukemia virus |
PBMC-B cells : 1.08% ; PBMC-Macrophages : 1.05% ; PBMC-T cells : 0.25% ; PBMC-Erythroid Progenitors : 0.15% ; PBMC-Dendritic cells : 0.00% ; |
|
Ross River virus |
PBMC-Erythroid Progenitors : 0.61% ; PBMC-T cells : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Dendritic cells : 0.00% ; |
|
Mayaro virus |
PBMC-Erythroid Progenitors : 0.61% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; PBMC-T cells : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Onyong-nyong virus |
PBMC-Erythroid Progenitors : 0.61% ; PBMC-B cells : 0.00% ; PBMC-Macrophages : 0.00% ; PBMC-Dendritic cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
|
Hepatitis delta virus |
PBMC-Erythroid Progenitors : 0.46% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Macrophages : 0.00% ; PBMC-Dendritic cells : 0.00% ; |